Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Joint Efforts: RheumPAC Facilitates Progress

From the College  |  June 7, 2018

Advocacy and RheumPAC staff from the ACR and other medical specialty organizations gathered in Nashville this month to discuss the importance of making sure your members know the details of the work advocacy and the PAC are doing.

Thus far, the ACR has had a very successful year in terms of its advocacy efforts. Following are just a few of the successes the ACR has helped achieve:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • The permanent repeal of the arbitrary caps on Medicare outpatient therapies;
  • Preventing the formation of the Independent Payment Advisory Board (IPAB). This board would have issued opinions carrying the weight of legislation with no congressional review;
  • Keeping Part B drug costs out of the MIPS calculation under MACRA;
  • Influencing the CMS to revisit pharmacy gag clauses;
  • Furthering federal step therapy reform legislation; and
  • Introducing a Senate companion bill that offers an electronic prior authorization option for Medicare Part D prescriptions.

We are proud of these accomplishments and will continue to fight for rheumatology by educating members of Congress and their staff on the issues affecting you, your practice, your research and your patients through RheumPAC, the only nonpartisan federal political action committee (PAC) dedicated solely to issues affecting rheumatology.

PAC Resources & a 3-Pronged System
Advocacy success is accomplished via a three-pronged system:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Political contributions from RheumPAC;
  2. Grassroots contact from member voters, who report the impact of policies on rheumatology professionals and patients in their district through constituent communications and Hill visits; and
  3. Our professional staff lobbyists, who maintain communication with and educate elected officials and their staff on key rheumatology-related issues.

PACs allow for large groups of people with a singular shared interest to have a voice in politics. An organization like the ACR/ARHP represents a varied group of rheumatology professionals that shares one voice and lobbies for their collective professional policy interests. In this way, the College unifies member resources to support full-time lobbyists, and build and maintain relationships with the 500-plus members of Congress.

RheumPAC’s resources comprise generous contributions from ACR/ARHP members, who understand the importance of having a strong voice in the policy process. All disbursements from RheumPAC are considered and voted on by ACR/ARHP members representing various regions, areas of practice and political opinions.

Thank You to RheumPAC Investors
Our successes in 2018 are due to all of our RheumPAC investors, who have contributed more than $60,000 to our efforts this year; so far, 2018 is on track to be record setting in both participation and dollars. Every name and every dollar increase our influence in Washington, D.C., in this important election year.

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR advocacyLeadership CirclePlatinum ClubRheumPACRheumPAC investors

Related Articles

    PAC a Punch on Capitol Hill

    May 1, 2007

    New political action committee will be a voice for rheumatology

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences